Filing Details
- Accession Number:
- 0001455244-10-000095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-15 13:00:00
- Reporting Period:
- 2010-04-13
- Filing Date:
- 2010-04-15
- Accepted Time:
- 2010-04-15 17:42:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 72444 | Nabi Biopharmaceuticals | NABI | Biological Products, (No Disgnostic Substances) (2836) | 591212264 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1459477 | W. Matthew Kalnik | 8610 Fernwood Road Bethesda MD 20817 | Svp Strategic Plan. & Bus. Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-04-13 | 2,250 | $5.78 | 47,350 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
Billionaire Hedge Funds
